Tue, 06 Feb 2024 16:00:57 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.3 https://www.oncologynurseadvisor.com/wp-content/uploads/sites/13/2024/01/cropped-CTA-ONA-HEM-favicon-32x32.png 32 32 https://www.oncologynurseadvisor.com/home/cancer-types/sarcoma/neoadjuvant-trabectedin-noninferior-to-standard-care-for-high-grade-myxoid-liposarcoma/ Tue, 06 Feb 2024 15:40:00 +0000 https://www.oncologynurseadvisor.com/?p=116319 https://www.oncologynurseadvisor.com/home/cancer-types/sarcoma/sabr-oligometastatic-soft-tissue-sarcoma/ Fri, 19 Jan 2024 15:20:00 +0000 https://www.oncologynurseadvisor.com/?p=116020 https://www.oncologynurseadvisor.com/home/cancer-types/sarcoma/atezolizumab-can-induce-response-in-alveolar-soft-part-sarcoma/ Fri, 15 Sep 2023 14:00:00 +0000 https://www.oncologynurseadvisor.com/?p=110417 Anti-PD-L1 agent induces sustained responses seen in about one-third of patients with advanced alveolar soft part sarcoma.]]> https://www.oncologynurseadvisor.com/home/cancer-types/sarcoma/pembrolizumab-produces-responses-in-some-rare-sarcomas/ Thu, 20 Jul 2023 14:40:00 +0000 https://www.oncologynurseadvisor.com/?p=109291 Pembrolizumab yielded responses in patients with chordoma, desmoplastic small round cell tumors, epithelioid sarcoma, and other rare sarcomas. ]]> https://www.oncologynurseadvisor.com/home/cancer-types/sarcoma/koebner-phenomenon-kaposi-sarcoma-case-series-link-treatment-risk/ Mon, 27 Feb 2023 15:50:00 +0000 https://www.oncologynurseadvisor.com/?p=105395 Researchers described possible associations between Kaposi sarcoma and Koebner phenomenon in a case series of patients with lesions appearing after a prior cutaneous injury.]]> https://www.oncologynurseadvisor.com/home/cancer-types/sarcoma/intratumoral-microbiome-soft-tissue-sarcoma-prognosis-treatment-risk/ Wed, 15 Feb 2023 16:00:00 +0000 https://www.oncologynurseadvisor.com/?p=105048 Researchers explored the possibility of an intratumoral microbiome being present in soft tissue sarcoma, similar to other cancer types.]]> https://www.oncologynurseadvisor.com/home/cancer-types/sarcoma/kit-mutation-location-impacts-response-tkis-gist/ Wed, 08 Feb 2023 15:30:00 +0000 https://www.oncologynurseadvisor.com/?p=104777 The location of KIT mutations is associated with response to ripretinib and sunitinib in patients with previously treated GIST, research suggests. ]]> https://www.oncologynurseadvisor.com/home/cancer-types/sarcoma/tecentriq-approved-for-unresectable-or-metastatic-alveolar-soft-part-sarcoma/ Mon, 09 Jan 2023 15:00:00 +0000 https://www.empr.com/?p=189249 The approval was based on data from a phase 2 study that included 49 patients with unresectable or metastatic ASPS.]]> https://www.oncologynurseadvisor.com/home/cancer-types/sarcoma/shorter-regimen-of-radiotherapy-safe-for-soft-tissue-sarcoma/ Tue, 29 Nov 2022 15:00:00 +0000 https://www.oncologynurseadvisor.com/?p=103399 Findings with preoperative radiotherapy administered to dose of 42.75 Gy in 15 fractions for three weeks.]]> https://www.oncologynurseadvisor.com/home/cancer-types/sarcoma/leiomyosarcoma-trabectedin-improves-pfs/ Mon, 01 Aug 2022 14:20:00 +0000 https://www.oncologynurseadvisor.com/?p=100990 Adding trabectedin to doxorubicin doubled the median progression-free survival. ]]>